Background: A scoping review was conducted to examine the breadth of evidence related to
telehealth innovations being utilized in the treatment of opioid use disorder (OUD) with …

Background: Methadone and buprenorphine are effective medications for opioid use
disorder (MOUD) that are highly regulated in the United States. The on-going opioid crisis …

Importance The demand for medications for opioid use disorder (MOUD) in rural US
counties far outweighs their availability. Novel approaches to extend treatment capacity …

Telemedicine is increasingly being used to treat patients with opioid use disorder (OUD). It
has particular value in rural areas of the United States impacted by the opioid crisis as these …

Introduction The COVID pandemic prompted a significant increase in the utilization of
telemedicine (TM) for substance use disorder (SUD) treatment. As we transition towards a …

Telemedicine could improve access to medications for opioid use disorder (MOUD).
Telemedicine-delivered MOUD (TMOUD) has expanded substantially in response to the …

Background Following the national implementation of the Affordable Care Act (ACA) in
2014, barriers still exist that limit the adoption of substance use treatment (SUT) services in …

Over 10 million individuals pass through US detention centers on an annual basis, with
nearly two-thirds meeting criteria for drug dependence/abuse. Despite proven efficacy …

Importance Amid rapid and widespread adoption of telehealth-based opioid treatment
(TBOT), there is an urgent need for rigorous studies exploring the feasibility and …

Introduction The COVID-19 pandemic has instigated the development of telemedicine-
mediated provision of medications for opioid use disorder such as buprenorphine and …